May 5, 2026
Day 1
8:00-8:45 Mentoring Breakfast (Academic Careers in DD)
Registration, light breakfast, and coffee
9:00 GCC Welcome: Suzanne Tomlinson-Mathis
IDDD Welcome: David Kummer, MD Anderson Cancer Center
Session 1 Neurodegenerative Diseases
Convenor David Kummer, MD Anderson Cancer Center
9:10-9:45 Keynote Presentation
Talk title tba
Alison Goate, Icahn School of Medicine at Mount Sinai
9:45-10:10 Talk title tba
Jim Ray, MD Anderson Cancer Center
10:10-10:35 Talk title tba
Jeannie Chin, Baylor College of Medicine
10:35-11:05 Vendor Show and Networking Break
11:05-11:30 TBA
11:30-11:55 TBA
11:55-1:30 Lunch-Event hall
Session 2 Induced Proximity Therapeutics
Convenors Jin Wan, Baylor College of Medicine
1:30-2:05 Keynote Presentation
Talk title tba
Ryan Potts, Amgen, Inc.
2:05-2:30 Talk title tba
Mingxing Teng, Baylor College of Medicine
2:30-2:55 Talk title tba
Hojong Yoon, MD Anderson Cancer Center
2:55-3:20 Talk title tba
Brian Liau, Harvard University
3:20-3:35 Networking Break
Session 3 Core Showcase
Convenors Suzanne Tomlinson-Mathis
3:35-4:15 5 min each
Session 4 Local Resources
Convenors Suzanne Tomlinson-Mathis
4:15-5:00 5 min each
5:00-6:15 Poster Session-odd-numbered posters & Networking Reception-Event hall
May 6, 2024
Day 2
8:00-8:45 Mentoring Breakfast (Industry Careers in DD)
Registration, light breakfast, and coffee
9:00-9:35 Welcome: Nassim Beiranvand, TMC Accelerator for Cancer Therapeutics
Session 5 AI in DD
Conveners Jason Cross, IACS; MD Anderson Cancer Center
9:05-9:40 Keynote Presenter TBA
9:40-10:05 Talk title tba
Jon Stokes, McMaster University
10:05-10:30 Speaker 2 TBA
10:30-11:00 Vendor Show and Networking Break
11:00-11:25 Speaker 3 TBA
11:25-11:50 Speaker 4 TBA
11:50-1:30 Lunch and Poster Session-even-numbered posters
11:50 Lunch
12:30 Poster Session-even-numbered posters
Session 6 Cancer Focus
Convenor TBA
1:30-2:05 Keynote presenter TBA
2:05-3:00 talk title tba
Charles Manning, MD Anderson Cancer Center
3:00-3:25 talk title tba
Chandra Mohan, University of Houston
3:25-3:50 Harnessing Synthetic Lethality for Rational Immuno-Oncology Therapies
Weiyi Peng, University of Houston
3:25-3:40 Break
Session 7 Panel: Investor Perspective
Convenor Suzanne Tomlinson
3:40-4:30 Panelists TBA
4:30 Closing Remarks
TBA